Lekrolin 4% (40 mg / ml) 5 ml of eye drops
- $15.10
Trade name
of Lekrolin®
the International unlicensed
name Kromoglitsiyevaya acid
the Dosage form
Eye drops of 4% (40 mg/ml)
Structure
of 1 ml of solution contains
active agent – sodium kromoglikat 40 mg,
excipients: a benzalkoniya chloride, glycerin, polyvinyl alcohol, dinatrium edetat, water for injections. -
ShchESTVO
Description
Transparent, colourless or slightly yellowish color solution.
Pharmacotherapeutic group
Antiallergenic drugs, others. Kromoglitsiyevy acid.
The ATX S01GX01 code
the Pharmacological
Pharmacokinetics Absorption properties through a mucous membrane of an eye and system absorption - are insignificant. Biological availability after introduction of drops to an eye makes 0.03%. Sodium kromoglikat reversibly contacts proteins of plasma (65%). Sodium kromoglikat is not metabolized and and not removed with
bile or mochy. After parenteral use the eliminative elimination half-life in plasma makes 80 minutes.
The pharmacodynamics
of Lekrolin® antiallergic means which has membrane stabilizing effect interferes with degranulation of mast cells, and discharge from them of a histamine, bradykinin, leukotrienes (including, slowly reacting substance) and other biologically active agents. Most effectively at preventive use. Use of eye drops of Lekrolin® reduces the need for prescribing of steroids and antihistamines.
The full clinical effect in allergic diseases is reached in several days or weeks of drug treatment.
Indications
- allergic conjunctivitis
the Route of administration and doses
Adults and children are more senior than 8 years:
On 1-2 drop in each conjunctival sac 4 times a day.
Only on doctor's orders.
In seasonal allergic conjunctivitis the treatment needs to be begun right after emergence of the first symptoms or to apply preventively prior to the beginning of a season of emergence of pollen. The course of treatment is defined by the attending physician.
Side effects
At topical administration of Lekrolin® it is usually well transferred and symptoms of irritation of eyes meet seldom.
Often (& gt, 1/100)
- the short-term burning sensation, local irritation of eyes and quickly taking place misting of sight
is Very rare (& lt, 1/10000)
- allergic reactions
of the Contraindication
- hypersensitivity to drug components
- children's age up to 8 years
Medicinal interactions
did not note adverse interactions of Lekrolina® with other medicines Earlier.
Лекролин® can reduce the need for use of the ophthalmologic drugs containing glyukokortiko steroids.
Special instructions
Eye drops of Lekrolin® contain in quality of preservative a benzalkoniya chloride, and they should not be used when carrying contact lenses. Before instillation of eye drops the contact lenses should be taken out and inserted back not earlier than in 15 minutes after drug use.
The bottle needs to be closed after each use. It is not necessary to touch eyes a pipette tip.
Pregnancy and the period of a lactation
Drug should be used with care during pregnancy and feeding by a breast. Use of Lekrolina® during pregnancy and a lactation has to be clinically justified.
The feature of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms
Should be careful when driving or potentially dangerous mechanisms because of possible short-term misting of sight.
The overdose
Overdose is improbable as local and system absorption – are insignificant.
Symptoms: strengthening of side effect
Treatment: symptomatic.
The form of release and packing
On 5 ml of drug place in a transparent polyethylene bottle dropper with the firm screwing-up plastic cap of white color.
On 1 bottle together with the instruction for medical use in the state and Russian languages place in a pack from cardboard.
To Store storage conditions at a temperature not above 25 °C.
To store out of children's reach!
3 years
to Use a period of storage within 1 month after the first opening of a bottle.
Not to use after the expiration of the storage specified on packing
Prescription status
Without prescription
the Producer Sangteng AO, Niittyukhaankatu 20, 33720 Tampere, Finland
of Lekrolin®
the International unlicensed
name Kromoglitsiyevaya acid
the Dosage form
Eye drops of 4% (40 mg/ml)
Structure
of 1 ml of solution contains
active agent – sodium kromoglikat 40 mg,
excipients: a benzalkoniya chloride, glycerin, polyvinyl alcohol, dinatrium edetat, water for injections. -
ShchESTVO
Description
Transparent, colourless or slightly yellowish color solution.
Pharmacotherapeutic group
Antiallergenic drugs, others. Kromoglitsiyevy acid.
The ATX S01GX01 code
the Pharmacological
Pharmacokinetics Absorption properties through a mucous membrane of an eye and system absorption - are insignificant. Biological availability after introduction of drops to an eye makes 0.03%. Sodium kromoglikat reversibly contacts proteins of plasma (65%). Sodium kromoglikat is not metabolized and and not removed with
bile or mochy. After parenteral use the eliminative elimination half-life in plasma makes 80 minutes.
The pharmacodynamics
of Lekrolin® antiallergic means which has membrane stabilizing effect interferes with degranulation of mast cells, and discharge from them of a histamine, bradykinin, leukotrienes (including, slowly reacting substance) and other biologically active agents. Most effectively at preventive use. Use of eye drops of Lekrolin® reduces the need for prescribing of steroids and antihistamines.
The full clinical effect in allergic diseases is reached in several days or weeks of drug treatment.
Indications
- allergic conjunctivitis
the Route of administration and doses
Adults and children are more senior than 8 years:
On 1-2 drop in each conjunctival sac 4 times a day.
Only on doctor's orders.
In seasonal allergic conjunctivitis the treatment needs to be begun right after emergence of the first symptoms or to apply preventively prior to the beginning of a season of emergence of pollen. The course of treatment is defined by the attending physician.
Side effects
At topical administration of Lekrolin® it is usually well transferred and symptoms of irritation of eyes meet seldom.
Often (& gt, 1/100)
- the short-term burning sensation, local irritation of eyes and quickly taking place misting of sight
is Very rare (& lt, 1/10000)
- allergic reactions
of the Contraindication
- hypersensitivity to drug components
- children's age up to 8 years
Medicinal interactions
did not note adverse interactions of Lekrolina® with other medicines Earlier.
Лекролин® can reduce the need for use of the ophthalmologic drugs containing glyukokortiko steroids.
Special instructions
Eye drops of Lekrolin® contain in quality of preservative a benzalkoniya chloride, and they should not be used when carrying contact lenses. Before instillation of eye drops the contact lenses should be taken out and inserted back not earlier than in 15 minutes after drug use.
The bottle needs to be closed after each use. It is not necessary to touch eyes a pipette tip.
Pregnancy and the period of a lactation
Drug should be used with care during pregnancy and feeding by a breast. Use of Lekrolina® during pregnancy and a lactation has to be clinically justified.
The feature of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms
Should be careful when driving or potentially dangerous mechanisms because of possible short-term misting of sight.
The overdose
Overdose is improbable as local and system absorption – are insignificant.
Symptoms: strengthening of side effect
Treatment: symptomatic.
The form of release and packing
On 5 ml of drug place in a transparent polyethylene bottle dropper with the firm screwing-up plastic cap of white color.
On 1 bottle together with the instruction for medical use in the state and Russian languages place in a pack from cardboard.
To Store storage conditions at a temperature not above 25 °C.
To store out of children's reach!
3 years
to Use a period of storage within 1 month after the first opening of a bottle.
Not to use after the expiration of the storage specified on packing
Prescription status
Without prescription
the Producer Sangteng AO, Niittyukhaankatu 20, 33720 Tampere, Finland
Related Products
